Avalo Therapeutics, Inc. (AVTX)

21.26 -1.61 (-7.04%) USD  |  NASDAQ  |  May 08, 14:18
More

Avalo Therapeutics Total Operating Expenses (TTM)

Total Operating Expenses (TTM) Chart

View Total Operating Expenses (TTM) for AVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (TTM) Range, Past 5 Years

View Total Operating Expenses (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (TTM) Benchmarks

View Total Operating Expenses (TTM) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
AbbVie, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade